Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an announcement.
Asker Healthcare Group has announced its acquisition of 80% of Finmed SAS, a leading provider of medical devices and solutions in France. This strategic move marks Asker’s first acquisition in France, aiming to strengthen its presence in the large French healthcare market. The acquisition, which is pending regulatory approval, is expected to close in the fourth quarter of 2025 and positively impact the group’s EBITA margin.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK100.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe, providing medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care, and ensuring a sustainable value chain. Asker combines the entrepreneurial drive of local companies with the collective knowledge of a large group, employing over 4,000 people in 17 countries with revenues of SEK 16 billion.
Average Trading Volume: 416,719
Current Market Cap: SEK39.77B
See more data about ASKER stock on TipRanks’ Stock Analysis page.